Cite
HARVARD Citation
Escudier, B. et al. (2016). Open-label phase 2 trial of first-line everolimus monotherapy in patients with papillary metastatic renal cell carcinoma: RAPTOR final analysis. European journal of cancer. pp. 226-235. [Online].